Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl. 1993 Dec;(22):39–44. [PubMed] [Google Scholar]
- Casey D. E. The relationship of pharmacology to side effects. J Clin Psychiatry. 1997;58 (Suppl 10):55–62. [PubMed] [Google Scholar]
- Ereshefsky L. Pharmacokinetics and drug interactions: update for new antipsychotics. J Clin Psychiatry. 1996;57 (Suppl 11):12–25. [PubMed] [Google Scholar]
- Friedman J., Ault K., Powchik P. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine. Biol Psychiatry. 1997 Sep 15;42(6):522–523. doi: 10.1016/S0006-3223(97)00227-8. [DOI] [PubMed] [Google Scholar]
- Fulton B., Goa K. L. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs. 1997 Feb;53(2):281–298. doi: 10.2165/00003495-199753020-00007. [DOI] [PubMed] [Google Scholar]
- Gaito J. Gradient of interference by various frequencies on 60 Hz kindling behavior. Can J Neurol Sci. 1980 Aug;7(3):223–226. doi: 10.1017/s0317167100023246. [DOI] [PubMed] [Google Scholar]
- Jacob K. S. The use of multiple psychotropic medication in the treatment of mental disorders. Aust N Z J Psychiatry. 1995 Jun;29(2):186–189. doi: 10.1080/00048679509075908. [DOI] [PubMed] [Google Scholar]
- Tecott L. H., Kwong L. L., Uhr S., Peroutka S. J. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide. Biol Psychiatry. 1986 Oct;21(12):1114–1122. doi: 10.1016/0006-3223(86)90219-2. [DOI] [PubMed] [Google Scholar]
- Tueth M. J., Cheong J. A. Clinical uses of pimozide. South Med J. 1993 Mar;86(3):344–349. doi: 10.1097/00007611-199303000-00019. [DOI] [PubMed] [Google Scholar]